You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 110 No. 2, Aug 1962 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (7)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Tetracycline and Demethylchlortetracycline in Man

Comparative Antibiotic Activity of Serum During Repeated Doses

CALVIN M. KUNIN, M.D.

Arch Intern Med. 1962;110(2):166-169.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In 1957 McCormick et al.1 published an account of a new family of tetracycline derivatives, the demethyltetracyclines. In 1958 Kunin and Finland2 reported a comparative study of equal doses of tetracycline (TC) and demethylchlortetracycline (DMCT) in man in which they demonstrated quite clearly that DMCT was more active than TC against 3 test organisms (including a group A β-hemolytic streptococcus, a staphylococcus, as well as the customary organism used in tetracycline assays, Bacillus cereus) and produced significantly higher and more sustained anti-microbial levels by weight for each organism following oral ingestion. These studies were confirmed and extended by the reports of Sweeney et al.,3 Hirsch and Finland,4 Garrod and Waterworth,5 and others. The pertinent literature has been reviewed by Finland and Garrod6 and Kunin and Finland.7

The chemotherapeutic advantage of DMCT over TC has been shown to be due to: (1) delayed renal . . . [Full Text PDF of this Article]


Author Affiliations

CHARLOTTESVILLE, VA.

Departments of Preventive Medicine and Medicine, University of Virginia School of Medicine, Charlottesville, Va.


Footnotes

Submitted for publication Oct. 18, 1961.

This work was supported in part by a grant from Lederle Laboratories Division, American Cyanamid Company.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1962 American Medical Association. All Rights Reserved.